Polycythemia vera is not initiated by JAK2V617F mutation

Experimental Hematology

Volumn 35, Issue 1, 2007, Pages 32.e1-32.e9

  Nussenzveig, Roberto H ^a   Swierczek, Sabina I ^b   Jelinek, Jaroslav ^a   Gaikwad, Amos ^c   Liu, Enli ^c,d   Verstovsek, Srdan ^a   Prchal, Jaroslav F ^e   Prchal, Josef T ^b,f  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CENTER FOR CELL AND GENE THERAPY   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROPOIETIN; JANUS KINASE 2; LOCKED NUCLEIC ACID;

ALLELE; ARTICLE; BURST FORMING UNIT E; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HUMAN CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33845755386     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.11.012     Document Type: Article

References (28)

1. Skoda R., and Prchal J.T. Chronic myeloproliferative disorders-introduction. Semin Hematol 42 (2005) 181-183
2. Baxter E.J., Scott L.M., Campbell P.J., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054-1061
3. James C., Ugo V., Le Couedic J.P., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
4. Kralovics R., Passamonti F., Buser A.S., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
5. Levine R.L., Wadleigh M., Cools J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7 (2005) 387-397
6. Zhao R., Xing S., Li Z., et al. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem 280 (2005) 22788-22792
7. Ugo V., Marzac C., Teyssandier I., et al. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera. Exp Hematol 32 (2004) 179-187
8. Lacout C., Pisani D.F., Tulliez M., Moreau Gachelin F., Vainchenker W., and Villeval J.L. JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood 108 (2006) 1652-1660
9. Kralovics R., Guan Y., and Prchal J.T. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 30 (2002) 229-236
10. Kralovics R., Stockton D.W., and Prchal J.T. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood 102 (2003) 3793-3796
11. Kralovics R., Teo S.S., Li S., et al. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood 108 (2006) 1377-1380
12. Bellanne-Chantelot C., Chaumarel I., Labopin M., et al. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood 108 (2006) 346-352
13. Germer S., Holland M.J., and Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 10 (2000) 258-266
14. Jelinek J., and Prchal J.T. Oxygen-dependent regulation of erythropoiesis. Methods Enzymol 381 (2004) 201-210
15. Newton C.R., Graham A., Heptinstall L.E., et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17 (1989) 2503-2516
16. Petersen M., Nielsen C.B., Nielsen K.E., et al. The conformations of locked nucleic acids (LNA). J Mol Recognit 13 (2000) 44-53
17. Jelinek J., Oki Y., Gharibyan V., et al. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood 106 (2005) 3370-3373
18. Ahmadian A., Gharizadeh B., O'Meara D., Odeberg J., and Lundeberg J. Genotyping by apyrase-mediated allele-specific extension. Nucleic Acids Res 29 (2001) E121
19. Bottema C.D., and Sommer S.S. PCR amplification of specific alleles: rapid detection of known mutations and polymorphisms. Mutat Res 288 (1993) 93-102
20. Kaltenbock B., and Schneider R. Differential amplification kinetics for point mutation analysis by PCR. Biotechniques 24 (1998) 202-204,206
21. Latorra D., Campbell K., Wolter A., and Hurley J.M. Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers. Hum Mutat 22 (2003) 79-85
22. Liu E., Jelinek J., Pastore Y.D., Guan Y., Prchal J.F., and Prchal J.T. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 101 (2003) 3294-3301
23. Prchal J.F., and Axelrad A.A. Letter: Bone-marrow responses in polycythemia vera. N Engl J Med 290 (1974) 1382
24. Prchal J.F., Adamson J.W., Steinmann L., and Fialkow P.J. Human erythroid colony formation in vitro: evidence for clonal origin. J Cell Physiol 89 (1976) 489-492
25. Stopka T., Zivny J.H., Stopkova P., Prchal J.F., and Prchal J.T. Human hematopoietic progenitors express erythropoietin. Blood 91 (1998) 3766-3772
26. Latorra D., Arar K., and Hurley J.M. Design considerations and effects of LNA in PCR primers. Mol Cell Probes 17 (2003) 253-259
27. Scott L.M., Scott M.A., Campbell P.J., and Green A.R. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood 108 (2006) 2435-2437
28. Prchal J.T. Polycythemia vera and other primary polycythemias. Curr Opin Hematol 12 (2005) 112-116